Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve

Clinical trial NCT00225290 · TERMINATED

Trial details

NCT number: NCT00225290
Sponsor: TTY Biopharm
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2003-02-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.